Brief: Helix Biopharma posts Q3 loss per share c$0.02
14/06/2016 22:19
June 14 (Reuters) - Helix Biopharma Corp HBP.TO
* Helix Biopharma Corp announces third quarter fiscal 2016
results
* Q3 loss per share c$0.02
Source text for Eikon: ID:nMKW84KF1a
Further company coverage: HBP.TO
(Bengaluru Newsroom: +1 646 223 8780)
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020